However, UA administration can inhibit P62 accumulation and the P62-regulated expression of MDM2, thus correcting aberrant cell-cycle regulation by inhibiting Notch1 activation and delaying the prognosis of DN. The gene discussed is SQSTM1; the disease is liver dysplastic nodule.